C cumulative preclinical evidence validates CUR’s therapeutic potential as a natural anti-fibrotic agent in experimental settings, and shows great prospects for developing anti-fibrotic functional foods and clinical therapeutics, yet high-quality human clinical trials are still urgently needed to confirm its real-world...
Ling-Ji Deng, Xiao-Qin Liu, Hao-Yue Feng et al.· Drug Design, Development and...· 0 citations
This review outlines the mechanisms of action, safety, adverse effects, drug interactions, and the application of CUR-related nanocomposite products, thereby providing a foundation for in-depth research on its antifibrotic properties and clinical application.
Ting Luo, Jia Gao, Qing-Zhi Liang et al.· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.